Emcure Pharmaceuticals on Tuesday reported a 25 per cent increase in profit after tax to Rs 251 crore in the September quarter, aided by strong sales performance across domestic and export markets.
The drug firm posted a profit after tax (PAT) of Rs 202 crore during the July-September quarter of the last fiscal…
Read More
About The Author
